Bendroflumethiazide

Valsts: Jaunzēlande

Valoda: angļu

Klimata pārmaiņas: Medsafe (Medicines Safety Authority)

Aktīvā sastāvdaļa:

Bendroflumethiazide 2.5mg;  ;  

Pieejams no:

Ipca Pharma (NZ) Pty Limited

SNN (starptautisko nepatentēto nosaukumu):

Bendroflumethiazide 2.5 mg

Deva:

2.5 mg

Zāļu forma:

Tablet

Kompozīcija:

Active: Bendroflumethiazide 2.5mg     Excipient: Lactose Purified talc Starch Stearic acid

Vienības iepakojumā:

Blister pack, PVC/PVDC, 14 tablets

Klase:

Prescription

Receptes veids:

Prescription

Ražojis:

Ipca Laboratories Limited

Ārstēšanas norādes:

Bendrofluazide is indicated in the treatment of oedema associated with conditions such as: congestive heart failure, nephrotic syndrome and cirrhosis of the liver.

Produktu pārskats:

Package - Contents - Shelf Life: Blister pack, PVC/PVDC - 14 tablets - 24 months from date of manufacture stored at or below 25°C - Blister pack, PVC/PVDC - 28 tablets - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE - 500 tablets - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, HDPE - 1000 tablets - 24 months from date of manufacture stored at or below 25°C

Autorizācija datums:

2006-06-28